Tobacco use is an established risk factor for the development of several cancers; however,
far less work has been done to understand the effects of continued smoking on cancer …

Over the past decade, a multitude of targeted agents have been explored in the treatment of
advanced non–small cell lung cancer (NSCLC). Thus far, two broad classes of agents have …

Background We previously reported that Asian ethnicity was a favorable prognostic factor for
overall survival (OS) in non-small cell lung cancer (NSCLC). In this study, we performed a …

Background We previously showed that Asian ethnicity was an independent favorable
prognostic factor in non-small cell lung cancer (NSCLC). Many Asian NSCLC patients were …

Background Many studies have reported the prognostic value of haemoglobin level for
cancers. Whereas the prognostic impact of decreased pretreatment haemoglobin level on …

In contrast to endometritis, now diagnosed by cytological examination, the effect of
endocervical inflammation on reproductive performance has been inadequately …

PURPOSE: Knowledge of prognostic factors for advanced non-small-cell lung cancer
(NSCLC) patients eligible for second-line treatment is scarce. The aim of this study was to …

Innovative therapeutic agents have significantly improved outcome with an acceptable
safety profile in a substantial proportion of non-small cell lung cancer (NSCLC) patients, who …

Introduction Accurate, individualized prognostication for lung cancer patients requires the
integration of standard patient and pathologic factors, biological, genetic, and other …

Abstract Treatment decision-making for patients with incurable non-small cell lung cancer
(NSCLC) is complex due to the rapidly increasing number of treatments and discovery of …